Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Qsam Biosciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
QSAM
Over the counter
8731
https://qsambio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Qsam Biosciences Inc
QSAM ANNOUNCES REVERSE STOCK SPLIT RATIO AHEAD OF MERGER
- Apr 16th, 2024 12:30 pm
QSAM Biosciences Signs Definitive Agreement to be Acquired by Telix Pharmaceuticals
- Feb 7th, 2024 9:00 pm
QSAM Biosciences Signs Term Sheet to be Acquired by Telix Pharmaceuticals; Receives $2 Million Pre-Closing Collaboration and Option Fee
- Nov 14th, 2023 12:30 pm
QSAM Biosciences Provides Update to Shareholders on Phase 1 Progress and Preliminary Clinical Data
- Aug 16th, 2023 12:00 pm
QSAM Biosciences Adds the Nuclear Reactor at the University of Texas at Austin to its Radioisotope Production Supply Chain for its Bone Cancer Treatment Drug Candidate, CycloSam®
- Jun 14th, 2023 12:00 pm
QSAM Biosciences Expands its Study of CycloSam® in the Treatment of Bone Cancer; Opens Patient Enrollment at Key Chicago Center, Insight Hospital and Medical Center
- May 23rd, 2023 12:00 pm
QSAM Biosciences and RLS Announce Clinical and Commercial Supply Agreement for Promising Clinical-Stage Metastatic and Primary Bone Cancer Treatment, CycloSam®
- May 16th, 2023 12:30 pm
QSAM Biosciences Receives Second Key Patent in Europe for its Clinical Stage Radiopharmaceutical Drug Candidate, CycloSam®
- Apr 26th, 2023 12:00 pm
Scroll